| 1 | maternal | 15,724 |
| 2 | paternal | 376 |
| 3 | prediagnostic | 52 |
| 4 | convalescent-phase | 13 |
| 5 | pre-diagnostic | 13 |
| 6 | midparental | 11 |
| 7 | approach-related | 10 |
| 8 | k/bxn | 8 |
| 9 | maternal-neonatal | 8 |
| 10 | preillness | 7 |
| 11 | group-mean | 6 |
| 12 | hypomagnesemia-induced | 6 |
| 13 | pradigastat | 6 |
| 14 | subdominant | 6 |
| 15 | skunk | 5 |
| 16 | albumin-adjusted | 4 |
| 17 | cord-maternal | 4 |
| 18 | season-standardized | 4 |
| 19 | infant/maternal | 3 |
| 20 | oc-related | 3 |
| 21 | phenotype-specific | 3 |
| 22 | pla-based | 3 |
| 23 | post-dinner | 3 |
| 24 | pre-rtx | 3 |
| 25 | rivax-specific | 3 |
| 26 | syphilis-associated | 3 |
| 27 | 1st-hour | 2 |
| 28 | 4-500mcg | 2 |
| 29 | diarrhea-associated | 2 |
| 30 | drug-contained | 2 |
| 31 | drug-medicated | 2 |
| 32 | ezw-containing | 2 |
| 33 | female-related | 2 |
| 34 | non-chemotherapy-induced | 2 |
| 35 | non-dairy | 2 |
| 36 | pmma/tnts | 2 |
| 37 | thrombocytopenia-related | 2 |
| 38 | 'bci | 1 |
| 39 | 24st-hour | 1 |
| 40 | 266,269 | 1 |
| 41 | 3rd-trimester | 1 |
| 42 | 400,000-450,000 | 1 |
| 43 | 8,040 | 1 |
| 44 | ama1-specific | 1 |
| 45 | b-subgroup-without | 1 |
| 46 | cinacalcet-induced | 1 |
| 47 | complement-inactivated | 1 |
| 48 | csf-rich | 1 |
| 49 | cytology-detected | 1 |
| 50 | diaminooxidase | 1 |
| 51 | events.• | 1 |
| 52 | fyua-specific | 1 |
| 53 | glucose-6-phosphate-isomerase | 1 |
| 54 | immunoassay-derived | 1 |
| 55 | lt-specific | 1 |
| 56 | magnesemium | 1 |
| 57 | mother-fetus-infant | 1 |
| 58 | mucin/bovine | 1 |
| 59 | postimmunotherapy | 1 |
| 60 | pre-evacuation | 1 |
| 61 | qyyyg-containing | 1 |
| 62 | rvhhp2-specific | 1 |
| 63 | sta/ml | 1 |
| 64 | tt-igg | 1 |
| 65 | wszg-containing | 1 |
| 66 | β-lactoglobulin-specific | 1 |
| 1 | 'bci | 1 |
| 2 | 1st-hour | 2 |
| 3 | 24st-hour | 1 |
| 4 | 266,269 | 1 |
| 5 | 3rd-trimester | 1 |
| 6 | 4-500mcg | 2 |
| 7 | 400,000-450,000 | 1 |
| 8 | 8,040 | 1 |
| 9 | albumin-adjusted | 4 |
| 10 | ama1-specific | 1 |
| 11 | approach-related | 10 |
| 12 | b-subgroup-without | 1 |
| 13 | cinacalcet-induced | 1 |
| 14 | complement-inactivated | 1 |
| 15 | convalescent-phase | 13 |
| 16 | cord-maternal | 4 |
| 17 | csf-rich | 1 |
| 18 | cytology-detected | 1 |
| 19 | diaminooxidase | 1 |
| 20 | diarrhea-associated | 2 |
| 21 | drug-contained | 2 |
| 22 | drug-medicated | 2 |
| 23 | events.• | 1 |
| 24 | ezw-containing | 2 |
| 25 | female-related | 2 |
| 26 | fyua-specific | 1 |
| 27 | glucose-6-phosphate-isomerase | 1 |
| 28 | group-mean | 6 |
| 29 | hypomagnesemia-induced | 6 |
| 30 | immunoassay-derived | 1 |
| 31 | infant/maternal | 3 |
| 32 | k/bxn | 8 |
| 33 | lt-specific | 1 |
| 34 | magnesemium | 1 |
| 35 | maternal | 15,724 |
| 36 | maternal-neonatal | 8 |
| 37 | midparental | 11 |
| 38 | mother-fetus-infant | 1 |
| 39 | mucin/bovine | 1 |
| 40 | non-chemotherapy-induced | 2 |
| 41 | non-dairy | 2 |
| 42 | oc-related | 3 |
| 43 | paternal | 376 |
| 44 | phenotype-specific | 3 |
| 45 | pla-based | 3 |
| 46 | pmma/tnts | 2 |
| 47 | post-dinner | 3 |
| 48 | postimmunotherapy | 1 |
| 49 | pradigastat | 6 |
| 50 | pre-diagnostic | 13 |
| 51 | pre-evacuation | 1 |
| 52 | pre-rtx | 3 |
| 53 | prediagnostic | 52 |
| 54 | preillness | 7 |
| 55 | qyyyg-containing | 1 |
| 56 | rivax-specific | 3 |
| 57 | rvhhp2-specific | 1 |
| 58 | season-standardized | 4 |
| 59 | skunk | 5 |
| 60 | sta/ml | 1 |
| 61 | subdominant | 6 |
| 62 | syphilis-associated | 3 |
| 63 | thrombocytopenia-related | 2 |
| 64 | tt-igg | 1 |
| 65 | wszg-containing | 1 |
| 66 | β-lactoglobulin-specific | 1 |
| 1 | 400,000-450,000 | 1 |
| 2 | 8,040 | 1 |
| 3 | 266,269 | 1 |
| 4 | ama1-specific | 1 |
| 5 | rvhhp2-specific | 1 |
| 6 | fyua-specific | 1 |
| 7 | phenotype-specific | 3 |
| 8 | β-lactoglobulin-specific | 1 |
| 9 | lt-specific | 1 |
| 10 | rivax-specific | 3 |
| 11 | pre-diagnostic | 13 |
| 12 | prediagnostic | 52 |
| 13 | hypomagnesemia-induced | 6 |
| 14 | cinacalcet-induced | 1 |
| 15 | non-chemotherapy-induced | 2 |
| 16 | drug-contained | 2 |
| 17 | pla-based | 3 |
| 18 | drug-medicated | 2 |
| 19 | diarrhea-associated | 2 |
| 20 | syphilis-associated | 3 |
| 21 | thrombocytopenia-related | 2 |
| 22 | oc-related | 3 |
| 23 | female-related | 2 |
| 24 | approach-related | 10 |
| 25 | complement-inactivated | 1 |
| 26 | cytology-detected | 1 |
| 27 | albumin-adjusted | 4 |
| 28 | immunoassay-derived | 1 |
| 29 | season-standardized | 4 |
| 30 | mucin/bovine | 1 |
| 31 | diaminooxidase | 1 |
| 32 | convalescent-phase | 13 |
| 33 | glucose-6-phosphate-isomerase | 1 |
| 34 | 4-500mcg | 2 |
| 35 | tt-igg | 1 |
| 36 | qyyyg-containing | 1 |
| 37 | wszg-containing | 1 |
| 38 | ezw-containing | 2 |
| 39 | csf-rich | 1 |
| 40 | 'bci | 1 |
| 41 | skunk | 5 |
| 42 | maternal | 15,724 |
| 43 | cord-maternal | 4 |
| 44 | infant/maternal | 3 |
| 45 | paternal | 376 |
| 46 | maternal-neonatal | 8 |
| 47 | midparental | 11 |
| 48 | sta/ml | 1 |
| 49 | magnesemium | 1 |
| 50 | group-mean | 6 |
| 51 | pre-evacuation | 1 |
| 52 | k/bxn | 8 |
| 53 | post-dinner | 3 |
| 54 | 3rd-trimester | 1 |
| 55 | 1st-hour | 2 |
| 56 | 24st-hour | 1 |
| 57 | preillness | 7 |
| 58 | pmma/tnts | 2 |
| 59 | pradigastat | 6 |
| 60 | mother-fetus-infant | 1 |
| 61 | subdominant | 6 |
| 62 | b-subgroup-without | 1 |
| 63 | pre-rtx | 3 |
| 64 | postimmunotherapy | 1 |
| 65 | non-dairy | 2 |
| 66 | events.• | 1 |